Patents by Inventor Chyi Lee

Chyi Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240120363
    Abstract: A self-aligned plug may be formed between deep trench isolation (DTI) etching cycles. Accordingly, etch depth in areas of a pixel sensor with large CDs (e.g., at an X-road) is reduced, which prevents trench loading. As a result, a floating diffusion (FD) region, associated with photodiodes of the pixel sensor, is not damaged during the DTI etching cycles. Reduced chances of damage to the FD region improves performance of the pixel sensor and prevents electrical shorts and failures, which increases yield and conserves time and raw materials used in forming the pixel sensor.
    Type: Application
    Filed: January 5, 2023
    Publication date: April 11, 2024
    Inventors: Ming-Chyi LIU, Jiech-Fun LU, Shih-Chang LIU, Ru-Liang LEE
  • Patent number: 11827629
    Abstract: Isoindoline compounds and their pharmaceutical compositions. Also provided are methods of treating a Cisd2-insufficiency associated disorder and protecting against doxorubicin-induced cardiotoxicity.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: November 28, 2023
    Assignees: National Health Research Institutes, National Yang Ming Chiao Tung University
    Inventors: Ting-Fen Tsai, Jinq-Chyi Lee, Teng-Kuang Yeh
  • Publication number: 20230100367
    Abstract: A method of treating a Cisd2 insufficiency-associated disorder. The method includes administering to a subject in need a compound of formula (I). Also disclosed is a method of increasing Cisd2 gene expression.
    Type: Application
    Filed: August 24, 2022
    Publication date: March 30, 2023
    Inventors: Ting-Fen Tsai, Jinq-Chyi Lee, Hui-Yi Shiao, Chi-Hsiao Yeh
  • Publication number: 20220411418
    Abstract: Isoindoline compounds and their pharmaceutical compositions. Also provided are methods of treating a Cisd2-insufficiency associated disorder and protecting against doxorubicin-induced cardiotoxicity.
    Type: Application
    Filed: May 25, 2022
    Publication date: December 29, 2022
    Inventors: Ting-Fen Tsai, Jinq-Chyi Lee, Teng-Kuang Yeh
  • Publication number: 20220152090
    Abstract: The present disclosure relates to a method for treating or preventing or delaying the onset or progression of an amyloidogenic disease in a subject in need, comprising administering a pharmaceutical composition comprising a therapeutically effective amount of amphiphilic liposaccharide to the subject. The present disclosure also relates to a method for selecting an agent for treating or preventing or delaying the onset or progression of an amyloidogenic disease and a novel liposaccharide.
    Type: Application
    Filed: November 12, 2021
    Publication date: May 19, 2022
    Inventors: Shu-Yi LIN, Jyh-Lyh JUANG, Jinq-Chyi LEE
  • Publication number: 20170290892
    Abstract: The unique polymeric OGF and enkephalin peptide conjugates with large size polymer attached at the C-terminus through hydrolysable linkage enhancing therapeutic properties of OGF and enkephalin peptides.
    Type: Application
    Filed: July 14, 2015
    Publication date: October 12, 2017
    Applicant: PEG BIOSCIENCES, INC.
    Inventor: Chyi LEE
  • Patent number: 9364553
    Abstract: The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: June 14, 2016
    Assignee: PEG Biosciences, Inc.
    Inventor: Chyi Lee
  • Publication number: 20150032842
    Abstract: In a web page provision method and system, a user terminal transmits to a server service data and a barcode generation request associated with the service data. The server generates a service web page corresponding to the service data, and a web address of the service web page. The server generates a web address alias based on the web address and at least one alternative web address at which a specific web page is located in response to the barcode generation request from the user terminal. The server generates a two-dimensional barcode corresponding to the web address alias.
    Type: Application
    Filed: July 26, 2013
    Publication date: January 29, 2015
    Inventors: Norman CHENG, Hwey-Chyi LEE
  • Publication number: 20140335051
    Abstract: The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies.
    Type: Application
    Filed: July 28, 2014
    Publication date: November 13, 2014
    Applicant: PEG Biosciences, Inc.
    Inventor: Chyi Lee
  • Patent number: 8712897
    Abstract: In a stock analysis method for performing an analysis on stocks to select target ones to be bought/sold from the stocks, each stock is grouped into a corresponding group based on stock return data thereof, market return data and industry return data of each corresponding classified industry. Clustering data for each stock corresponding to each time interval and associated with the groups is obtained based a clustering mode. Analysis data for each stock corresponding to a coming time interval is estimated based on the corresponding clustering data. Any ones of the stocks, whose analysis data matches predetermined selection criteria, are determined as the target stocks.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: April 29, 2014
    Inventors: Hwey-Chyi Lee, Sheng-Shyr Cheng
  • Patent number: 8697658
    Abstract: Compounds of formula (I): wherein X, Y, and Z are defined herein. Also disclosed are pharmaceutical compositions and therapeutical methods related to these compounds.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: April 15, 2014
    Assignee: National Health Research Institutes
    Inventors: Jinq-Chyi Lee, Yu-Sheng Chao
  • Publication number: 20130325747
    Abstract: In a stock analysis method for performing an analysis on stocks to select target ones to be bought/sold from the stocks, each stock is grouped into a corresponding group based on stock return data thereof, market return data and industry return data of each corresponding classified industry. Clustering data for each stock corresponding to each time interval and associated with the groups is obtained based a clustering mode. Analysis data for each stock corresponding to a coming time interval is estimated based on the corresponding clustering data. Any ones of the stocks, whose analysis data matches predetermined selection criteria, are determined as the target stocks.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 5, 2013
    Inventors: Hwey-Chyi LEE, Sheng-Shyr CHENG
  • Publication number: 20130195799
    Abstract: The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies.
    Type: Application
    Filed: August 19, 2011
    Publication date: August 1, 2013
    Applicant: PEG BIOSCIENCES, INC.
    Inventor: Chyi Lee
  • Patent number: 7985856
    Abstract: A method for preparing hexose derivatives comprises the steps of providing a silylated hexose, treating the silylated hexose with a first carbonyl compound in the presence of a catalyst to form an ketalized hexose, treating the ketalized hexose with a second carbonyl compound followed by treating with a first reductant to form an etherized hexose, and converting the etherized hexose into a target hexose derivative, which can be 2-alcohol hexose, 3-alcohol hexose, 4-alcohol hexose, or a 6-alcohol hexose. In particular, the present invention can prepare the hexose derivatives with highly regioselective scheme to protect individual hydroxyls of monosaccharide units and install an orthogonal protecting group pattern in a one-pot manner.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: July 26, 2011
    Assignee: National Tsing Hua University
    Inventors: Shang-Cheng Hung, Cheng-Chung Wang, Jinq Chyi Lee, Shun Yuan Luo, Suvarn Subhash Kulkarni, Yu Wen Huang, Chia Chen Lee, Ken Lien Chang
  • Patent number: 7683974
    Abstract: A detection device and method commonly used for a video interface outlet and earphone line outlet is used to allow the detection device to detect whether a three- or four-terminals plug is inserted in the outlet. The detection device detects whether the impedance value of the video output terminal of the plug is larger than the preset value. If yes, the detection device control a video signal output terminal to output a video signal. If the impedance is not larger than the preset value, the detection device then controls the video signal output not to output a video signal and only to output an audio signal.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: March 23, 2010
    Assignee: Kinpo Electronics Inc.
    Inventors: Chun-I Sun, Wen-Chyi Lee
  • Patent number: 7655769
    Abstract: Orthogonally protected disaccharide building blocks for synthesis of heparin saccharide are disclosed. The disaccharide building block has a formula (I), in which L is a leaving group, P1, P2, P3 and P4 are different, and of them P1 is an ester-type protecting group, P2 is a hydroxyl protecting group that could be oxidized to a carboxylic acid, P3 is a hydroxyl protecting group, and P4 is a hydroxyl protecting group which allows chemoselective deprotection with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). Acting as an elongation unit, the disaccharide building block of formula (I) may react with a starting unit of formula (II) to synthesize a heparin saccharide of desired size.
    Type: Grant
    Filed: January 7, 2008
    Date of Patent: February 2, 2010
    Assignee: Academia Sinica
    Inventors: Shang-Cheng Hung, Jing-Chyi Lee, Xin-An Lu
  • Publication number: 20090285780
    Abstract: PEG linker compounds and biologically active conjugates thereof having mixed functional group linkages attached to at least one PEG moeity, and a coupling group for attaching a biologically active molecule. The PEG mixed linkages can be the combinations of stable, or labile, or releasable, or stable and labile, or stable and releasable, or releasable and labile covalent linkages. The mixed functional linkages of the PEG linker compounds consist of different organic functional groups, which have non-equivalent half-life in plasma and, hence, they have different release rates in blood. The present invention also provides for attachment of novel PEG linker compounds with mixed functional linkages for Pegylation of biologically active molecules to produce Probiomolecule-PEG constructs. The Probiomolecule-PEG construct is the prodrug of biomolecule-PEG conjugate or biomolecule.
    Type: Application
    Filed: May 24, 2007
    Publication date: November 19, 2009
    Inventor: Chyi Lee
  • Patent number: 7582737
    Abstract: Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharide. The disaccharide building block has a formula (I), in which L is a leaving group, P1, P2, P3 and are different, and of them P1 is an ester-type protecting group, P2 is a hydroxyl protecting group that could be oxidized to a carboxylic acid, P3 is a hydroxyl protecting group, and P4 is a hydroxyl protecting group which allows chemoslective deprotection with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). Acting as an elongation unit, the disaccharide building block of formula (I) may react with a starting unit of formula (II) to synthesize a heparin oligosaccharide.
    Type: Grant
    Filed: July 20, 2005
    Date of Patent: September 1, 2009
    Assignee: Academia Sinica
    Inventors: Shang-Cheng Hung, Jing-Chyi Lee, Xin-An Lu
  • Publication number: 20080171722
    Abstract: The present invention provides composition and methods for the synthesis of low molecular weight heparins and heparinoids. The present invention also provides compositions having substantially homogenous populations of desired heparin molecules, or molecules useful in the synthesis of heparin oligosaccharides.
    Type: Application
    Filed: January 7, 2008
    Publication date: July 17, 2008
    Applicant: Academia Sinica, Office of Public Affairs (Technology Transfer)
    Inventors: Shang-Cheng Hung, Jing-Chyi Lee, Xin-An Lu
  • Publication number: 20060079483
    Abstract: The present invention provides composition and methods for the synthesis of low molecular weight heparins and heparinoids. The present invention also provides compositions having substantially homogenous populations of desired heparin molecules, or molecules useful in the synthesis of heparin oligosaccharides.
    Type: Application
    Filed: July 20, 2005
    Publication date: April 13, 2006
    Applicant: Academia Sinica
    Inventors: Shang-Cheng Hung, Jing-Chyi Lee, Xin-An Lu